Water contamination at Camp Lejeune in North Carolina between 1953 and 1987 caused cancers, birth defects, miscarriages and other side effects for U.S. Marines and their family members.

Millions of recalled Philips DreamStation, CPAP, BiPAP and ventilator machines may release toxic foam particles and chemicals into the air pathway.

Premature infants fed Similac or Enfamil cow's milk formula faced increased risk of necrotizing enterocolitis (NEC) or wrongful death.

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.

Problems with 3M Combat Arms earplugs have resulted in cases of military hearing loss.

Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug.

Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.

Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.

Cases reviewed for problems with several types of hernia repair products.

Volatile organic compounds found in the recalled Philips BiPAP machines can enter users' airways, putting them at risk of serious injury or death, according to an FDA update that categorized the problems as a Class I recall.

The U.S. Food and Drug Administration (FDA) announced this week that it has classified a Philips BiPAP machine recall issued last month as a Class I medical device recall, suggesting that exposure to the toxic chemicals released by plastic components in the motor may cause serious injuries or death.

Consumers were initially warned about the recalled Philips BiPAP machines on August 29, when the regulatory agency alerted patients, caregivers and healthcare providers that several models of breathing machines may be equipped with plastic in the motor which was contaminated with a non-compatible material, which could release volatile organic compounds (VOCs) directly into the air pathways and users lungs.

In an update posted on September 26, the FDA categorized the recall as a Class I, which is the most serious designation that the agency can apply, suggesting continued use of the recalled Philips BiPAP machines poses a substantial risk of serious adverse health consequences, including fatal side effects.

Did you or a loved one suffer side effects after using a recalled Philips BiPAP machine?

The recall includes approximately 386 Philips A-Series BiPAP A30 (Ventilator), A-Series BiPAP A40 (Ventilator), A-Series BiPAP V30 (Auto Ventilator) and OmniLab Advanced+ models, which are used in both at-home and clinical environments, such as hospitals and sleep laboratories. The devices were distributed from August 6, 2020, to September 1, 2021.

Defects with the Philips BiPAP may cause toxic VOCs to enter the lungs, causing a variety of symptoms including headache, dizziness, and irritation in the eyes, nose, respiratory tract (airway), and skin, hypersensitivity reaction, immune system reactions, nausea or vomiting, and toxic cancer-causing effects.

The reclassification of the BiPAP recall comes as the manufacturer is still reeling from problems which led to a recall of several million Philips CPAP, BiPAP and ventilator machines distributed between 2009 and April 2021 issued last year.

Some of the recalled Philips BiPAP machines were also included in this earlier action, which impacted machines distributed with a PE-PUR sound abatement foam  found to break down over time, releasing toxic black particles into the air pathways, tubing, mask and users lungs.

Thousands of Philips CPAP/BiPAP lawsuits are already being pursued following this 2021 recall, including allegations that users were left with various types of cancer, lung damage and respiratory side effects.

Millions of recalled Philips DreamStation, CPAP, BiPAP and ventilator machines may release toxic foam particles and chemicals into the air pathway.

Following the initial warnings about the sound abatement foam problems in June 2021, free replacement CPAP and BiPAP machines were not offered by the manufacturer, and Philips did not provide users the funds to buy a new sleep apnea machine, leaving them without much-needed breathing assistance. It was not until September 2021 that a Philips CPAP machine repair program was announced, which was initially expected to take up to a year to fulfill. However, one year later the manufacturer has failed to meet their deadlines.

In August 2022, the FDA issued an update on side effects from recalled Philips CPAP, BiPAP and ventilators, indicating it has received more than 69,000 adverse event reports involving problems associated with the foam particles, including 124 deaths.

Following the Philips BiPAP recall first announced last month, the agency has not indicated how many of those problems may be related to toxic chemicals released by plastic components in the motor.

With tens of thousands of Philips CPAP and BiPAP machine lawsuits likely to be filed throughout the federal court system, each raising similar questions of fact and law, coordinated pretrial proceedings for the litigation have been established before U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania.

Plaintiffs allege that Philips CPAP foam caused cancer to develop, or that chronic exposure to the foam particles resulted in various lung injuries, including pulmonary fibrosis, interstitial lung disease, sarcoidosis, and other conditions.

According to the latest docket report (PDF) issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on September 15, there are currently only 323 Philips CPAP claims filed before Judge Conti. However, the size and scope of the litigation is expected to rapidly increase over the remainder of 2022 and 2023, as thousands of additional claims have been registered on a tolling agreement.

Earlier this month, Judge Conti held a Philips CPAP lawsuit “show and tell” science day, where the parties made presentations to the court that were intended to provide education about scientific issues that will come up during the pretrial proceedings.

In the coming months, it is expected that Judge Conti will establish a “bellwether” process, where the parties will identify small groups of representative claims to prepare for early trial dates, which are designed to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the proceedings. However, if Philips CPAP machine settlements are not reached in the MDL, each claim may later be remanded to different U.S. District Courts nationwide for separate trial dates in the future.

"* " indicates required fields

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

A panel of federal judges has ordered all Exactech recall lawsuits consolidated for pretrial proceedings and centralized in the U.S. District Court for the Eastern District of New York.

Plaintiffs are asking a federal judge to issue a summary judgment which would prevent 3M from forcing plaintiffs to prove it is fully liable for their injuries.

Several federal judges have filed orders over the last month calling on plaintiffs who have filed Camp Lejeune lawsuits to follow the proper filing procedures in order to prevent their claim from being denied.

Site Sponsored By: Saiontz & Kirk, P.A

©2022 Copyright AboutLawsuits.com. All Rights Reserved